WYNZORA Cream结合了卡泊三烯作为合成维生素D3模拟物和倍他米松二丙酸酯作为合成皮质类固醇的药理作用。然而,尽管它们的药理和临床作用是已知的,但它们在血吸虫病中作用的确切机理尚不清楚。 【Wynzora乳膏适应症和用途】 WYNZORA乳膏是钙磷三烯(一种维生素D类似物)和倍他米松二丙酸酯(一种皮质类固醇)的组合,适用于...
近日,美国食品药品监督管理局(FDA)批准新型组合外用乳膏Wynzora(calcipotriene and betamethasone dipropionate中文译名:骨化三烯和倍他米松二丙酸酯,w/w 0.005%/0.064%)上市,用于每天一次局部治疗18岁以上成人的斑块状牛皮癣。 Wynzora Cream是卡泊三烯和倍他米松二丙酸酯的乳膏固定剂量组合,用于局部治疗斑块状牛皮癣,...
原文出处:MC2 Therapeutics Announces U.S. Food and Drug Administrationapproval of Wynzora Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) for Adults with Plaque Psoriasis
(生物谷Bioon.com) 原文出处:MC2 Therapeutics Announces U.S. Food and Drug Administrationapproval of Wynzora Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) for Adults with Plaque Psoriasis
†Wynzora cream (37.4%) was noninferior to calcipotriene/betamethasone dipropionate topical suspension, 0.005%/0.064% (22.8%) for the primary endpoint of treatment success at week 8.7 ‡When used as directed. §At participating pharmacies. Limitations apply. Reduced copay for commercially insured...
每日1次,外用于患处,持续8周,每周不超过100克。当斑块型银屑病得到控制时,患者应停止治疗。 商品名:Wynzora Cream 通用名:calcipotriene and betamethasone dipropionate w/w 0.005%/0.064% 钙泊三醇/二丙酸倍他米松 乳膏剂 制药商:Almirall Limited/西班牙艾美罗制药有限公司 规格:120g/盒 索引:银屑病...
2022年02月18日(巴塞罗那) 西班牙Almirall医药公司宣布,在首批欧洲国家(西班牙、德国、英国)推出Wynzora乳膏(钙泊三醇和二丙酸倍他米松,CAL/BDP,w/w,0.005%/0.064%):该药作为每日一次的外用疗法,用于≥18岁成人治疗轻度至中度斑块型银屑病,包括头皮部位。
Safety and effectiveness of the use of Wynzora Cream in adolescents and pediatric patients under the age of 18 years have not been established. Because of a higher ratio of skin surface area to body mass, pediatric patients are at a greater risk than adults of systemic toxicity when treated ...